EPCAM and hepatocellular carcinoma: Overall survival and disease-free survival were evaluated for 152 patients, including 61 cases of EpCAM(−)/K19(−) HCC, 35 cases of EpCAM(+)/K19(+) HCC, and 56 cases of cHC-CC.